Drug class in one race
TYK2/JAK1 drugs for Psoriasis
3 tracked TYK2/JAK1 drugs in the Psoriasis race. The class explanation lives on the TYK2/JAK1 page; the full indication pipeline across every mechanism is on the Psoriasis page.
3 Phase 2
Head-to-head evidence: ICP-332 vs TLL-018 · brepocitinib vs ICP-332 · brepocitinib vs TLL-018